Skip to main content

Table 1 Sequence of systemic therapies administered since diagnosis of cutaneous T-cell lymphoma/ Sézary Syndrome

From: Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome

Prior therapy for CTCL/SSSequence and Duration
Photochemotherapy (PUVA)First Line of Therapy8 months (2009)
PhotopheresisSecond Line of Therapy31 months (2009–2012)
RomidepsinThird Line of Therapy48 months (2010–2014)
Pegylated liposomal doxorubicinFourth Line of Therapy3 months (2014)
GemcitabineFifth Line of Therapy1 month (2014)
AlemtuzumabSixth Line of Therapy2 months (2015)
MogamulizumabSeventh Line of Therapy1 month (2015)
Total skin electron beam therapyEighth Line of Therapy3 months (2016)
BexaroteneNinth Line of Therapy2 months (2016)
PralatrexateTenth Line of Therapy2 months (2016)
ICE (Ifosfamide, Carboplatin, Etoposide)Eleventh Line of Therapy3 months (2016–2017)
Sibling allogenic stem cell transplantationTwelfth Line of Therapy(2017)